Clinical Trials : Conjunctivitis

Completed

Study Name: Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea
Condition: Conjunctivitis, Allergic
Date: 2013-11-13
Interventions: Drug: Relestat Ophthalmic Solution 0.05% Relestat Ophthalmic Solution 0.05% prescribed as local standard

Completed

Study Name: AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Date: 2014-03-06
Interventions: Drug: AGN-229666 One to two drops of AGN-229666 twice daily in each eye for 10 weeks.

Completed

Study Name: Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea
Condition: Conjunctivitis, Allergic
Date: 2015-09-18
Interventions: Drug: Alcaftadine Ophthalmic Solution 0.25% Alcaftadine Ophthalmic Solution 0.25% (Lastacaft®) as p

Completed

Study Name: A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Date: 2012-11-19
Interventions:

Drug: Alcaftadine 0.25% One dr

Completed

Study Name: Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Date: 2012-12-04
Interventions:

Drug: AL-4943A ophthalmic solution
Drug: O

Completed

Study Name: Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Date: 2014-03-04
Interventions:

Drug: AL-53817 Ophthalmic Solution, 0.1%
D

Completed

Study Name: Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Date: 2011-03-18
Interventions:

Drug: SPARC1102 I SPARC1102 I

Completed

Study Name: Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Date: 2006-05-30
Interventions: Drug: olopatadine 0.2%

Completed

Study Name: A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Date: 2011-05-30
Interventions: Drug: DE-114 ophthalmic solution

Completed

Study Name: Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis
Condition: Conjunctivitis, Bacterial
Date: 2006-07-25
Interventions: Drug: Azithromycin (T1225)

Search for Clinical Trial Results

Conjunctivitis - 119 Studies Found

Status	Study
Completed	Study Name: Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea Condition: Conjunctivitis, Allergic Date: 2013-11-13 Interventions: Drug: Relestat Ophthalmic Solution 0.05% Relestat Ophthalmic Solution 0.05% prescribed as local standard
Completed	Study Name: AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis Condition: Conjunctivitis, Allergic Date: 2014-03-06 Interventions: Drug: AGN-229666 One to two drops of AGN-229666 twice daily in each eye for 10 weeks.
Completed	Study Name: Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea Condition: Conjunctivitis, Allergic Date: 2015-09-18 Interventions: Drug: Alcaftadine Ophthalmic Solution 0.25% Alcaftadine Ophthalmic Solution 0.25% (Lastacaft®) as p
Completed	Study Name: A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis Condition: Conjunctivitis, Allergic Date: 2012-11-19 Interventions: Drug: Alcaftadine 0.25% One dr
Completed	Study Name: Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis Condition: Allergic Conjunctivitis Date: 2012-12-04 Interventions: Drug: AL-4943A ophthalmic solution Drug: O
Completed	Study Name: Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis Condition: Allergic Conjunctivitis Date: 2014-03-04 Interventions: Drug: AL-53817 Ophthalmic Solution, 0.1% D
Completed	Study Name: Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis Condition: Allergic Conjunctivitis Date: 2011-03-18 Interventions: Drug: SPARC1102 I SPARC1102 I
Completed	Study Name: Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis Condition: Allergic Conjunctivitis Date: 2006-05-30 Interventions: Drug: olopatadine 0.2%
Completed	Study Name: A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis Condition: Allergic Conjunctivitis Date: 2011-05-30 Interventions: Drug: DE-114 ophthalmic solution
Completed	Study Name: Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis Condition: Conjunctivitis, Bacterial Date: 2006-07-25 Interventions: Drug: Azithromycin (T1225)